AbbVie and Eli Lilly snub drug pricing agreement
16th January 2023 Uncategorised 0Major industry names depart leaving UK pricing deal in serious jeopardy More: AbbVie and Eli Lilly snub drug pricing agreement Source: News
read more
Major industry names depart leaving UK pricing deal in serious jeopardy More: AbbVie and Eli Lilly snub drug pricing agreement Source: News
read moreEMA looks to warn doctors of Zolgensma’s liver failure deaths amid discussion with Novartis aliu Fri, 01/13/2023 – 11:08 More: EMA looks to warn doctors of Zolgensma's liver failure deaths amid discussion with Novartis Source: fierce
read moreModerna’s proposed Spikevax price hikes ‘hard to justify,’ White House says zbecker Fri, 01/13/2023 – 11:07 More: Moderna's proposed Spikevax price hikes 'hard to justify,' White House says Source: fierce
read moreAmerisourceBergen Expands Global Footprint and Commercialization Solutions with Acquisition of PharmaLex jpiatt Fri, 01/13/2023 – 10:18 More: AmerisourceBergen Expands Global Footprint and Commercialization Solutions with Acquisition of PharmaLex Source: fierce
read moreRoche searches pharma chief Anderson’s successor from within: chairman aliu Fri, 01/13/2023 – 09:36 More: Roche searches pharma chief Anderson's successor from within: chairman Source: fierce
read moreNew Biogen CEO tips subcutaneous lecanemab to help expansion into pre-symptomatic Alzheimer’s ntaylor Fri, 01/13/2023 – 09:33 More: New Biogen CEO tips subcutaneous lecanemab to help expansion into pre-symptomatic Alzheimer’s Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals